SUBSCRIBE
SUBSCRIBE
BioCapital

Genzyme Corporation To End Rationing Of Cerezyme In September; U.S. Patients Can Resume Normal Dosing

August 26, 2010 | 
1 min read

BOSTON Aug 26 (Reuters) - Genzyme Corp (GENZ.O) said it will end rationing of the Gaucher disease drug Cerezyme for U.S. patients in September, restoring full supplies of the medicine.

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: FDA sign at its office in Washington, DC/iStock, JHVEPhoto
Policy
FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease
April 8, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: 3d illustration of hepatitis B viruses i
Drug Development
Altimmune Axes Hepatitis B Program After Phase II Failure, Focuses on Obesity and MASH
March 28, 2024
 · 
1 min read
 · 
Tyler Patchen